Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
The impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis
F Ricci, A Tedeschi, E Vismara, et al.
Recenti Progressi in Medicina
|
October 1, 1992
[The soluble IL-2 receptor in malignant hemopathies]
S Rupoli, M Montillo, A Salvi, et al.
Cancer
|
November 26, 1999
Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes
F Ferrara, F Leoni, A Pinto, et al.
The American Journal of Emergency Medicine
|
February 4, 2018
Shortened preprocedural fasting in the pediatric emergency department
Corrie E Chumpitazi, Elizabeth A Camp, Divya R Bhamidipati, et al.
Recenti Progressi in Medicina
|
March 1, 1993
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]
A Olivieri, P Leoni, L Ciniero, et al.
British Journal of Haematology
|
March 1, 1995
Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto)
L Pagano, P Ricci, A Nosari, et al.
British Journal of Haematology
|
December 31, 1997
Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto)
L Pagano, P Ricci, A Tonso, et al.
Leukemia
|
February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group
A M Carella, P Carlier, E Pungolino, et al.
Haematologica
|
October 1, 1989
[Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)]
A Del Favero, P Martino, G Bucaneve, et al.
American Journal of Hematology
|
June 13, 1998
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
M Montillo, S Mirto, M C Petti, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Clinical Lymphoma, Myeloma & Leukemia
|
April 2, 2011
The impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis
F Ricci, A Tedeschi, E Vismara, et al.
Recenti Progressi in Medicina
|
October 1, 1992
[The soluble IL-2 receptor in malignant hemopathies]
S Rupoli, M Montillo, A Salvi, et al.
Cancer
|
November 26, 1999
Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes
F Ferrara, F Leoni, A Pinto, et al.
The American Journal of Emergency Medicine
|
February 4, 2018
Shortened preprocedural fasting in the pediatric emergency department
Corrie E Chumpitazi, Elizabeth A Camp, Divya R Bhamidipati, et al.
Recenti Progressi in Medicina
|
March 1, 1993
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]
A Olivieri, P Leoni, L Ciniero, et al.
British Journal of Haematology
|
March 1, 1995
Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto)
L Pagano, P Ricci, A Nosari, et al.
British Journal of Haematology
|
December 31, 1997
Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto)
L Pagano, P Ricci, A Tonso, et al.
Leukemia
|
February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group
A M Carella, P Carlier, E Pungolino, et al.
Haematologica
|
October 1, 1989
[Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)]
A Del Favero, P Martino, G Bucaneve, et al.
American Journal of Hematology
|
June 13, 1998
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
M Montillo, S Mirto, M C Petti, et al.
Page
of 7